RedHill Biopharma (RDHL) Competitors $6.50 +0.03 (+0.46%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends RDHL vs. CALC, TPST, BRNS, AFMD, OKYO, ANEB, VRCA, OTLK, SRZN, and IXHLShould you be buying RedHill Biopharma stock or one of its competitors? The main competitors of RedHill Biopharma include CalciMedica (CALC), Tempest Therapeutics (TPST), Barinthus Biotherapeutics (BRNS), Affimed (AFMD), OKYO Pharma (OKYO), Anebulo Pharmaceuticals (ANEB), Verrica Pharmaceuticals (VRCA), Outlook Therapeutics (OTLK), Surrozen (SRZN), and Incannex Healthcare (IXHL). These companies are all part of the "pharmaceutical products" industry. RedHill Biopharma vs. CalciMedica Tempest Therapeutics Barinthus Biotherapeutics Affimed OKYO Pharma Anebulo Pharmaceuticals Verrica Pharmaceuticals Outlook Therapeutics Surrozen Incannex Healthcare RedHill Biopharma (NASDAQ:RDHL) and CalciMedica (NASDAQ:CALC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability. Do analysts prefer RDHL or CALC? CalciMedica has a consensus price target of $19.33, suggesting a potential upside of 600.48%. Given CalciMedica's stronger consensus rating and higher possible upside, analysts plainly believe CalciMedica is more favorable than RedHill Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RedHill Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CalciMedica 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is RDHL or CALC more profitable? RedHill Biopharma's return on equity of 0.00% beat CalciMedica's return on equity.Company Net Margins Return on Equity Return on Assets RedHill BiopharmaN/A N/A N/A CalciMedica N/A -164.24%-103.53% Does the media prefer RDHL or CALC? In the previous week, CalciMedica had 1 more articles in the media than RedHill Biopharma. MarketBeat recorded 1 mentions for CalciMedica and 0 mentions for RedHill Biopharma. RedHill Biopharma's average media sentiment score of 0.00 equaled CalciMedica'saverage media sentiment score. Company Overall Sentiment RedHill Biopharma Neutral CalciMedica Neutral Which has stronger valuation and earnings, RDHL or CALC? RedHill Biopharma has higher revenue and earnings than CalciMedica. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedHill Biopharma$3.71M2.25$23.92MN/AN/ACalciMedicaN/AN/A-$34.36M-$1.08-2.56 Do institutionals and insiders hold more shares of RDHL or CALC? 7.2% of RedHill Biopharma shares are owned by institutional investors. 6.8% of RedHill Biopharma shares are owned by insiders. Comparatively, 41.5% of CalciMedica shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community favor RDHL or CALC? RedHill Biopharma received 412 more outperform votes than CalciMedica when rated by MarketBeat users. However, 93.75% of users gave CalciMedica an outperform vote while only 67.56% of users gave RedHill Biopharma an outperform vote. CompanyUnderperformOutperformRedHill BiopharmaOutperform Votes42767.56% Underperform Votes20532.44% CalciMedicaOutperform Votes1593.75% Underperform Votes16.25% Which has more volatility and risk, RDHL or CALC? RedHill Biopharma has a beta of 3.65, meaning that its share price is 265% more volatile than the S&P 500. Comparatively, CalciMedica has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. SummaryRedHill Biopharma beats CalciMedica on 7 of the 13 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDHL vs. The Competition Export to ExcelMetricRedHill BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.33M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E RatioN/A10.5990.0517.18Price / Sales2.25195.801,117.14116.99Price / Cash0.0157.1643.0437.86Price / Book0.165.094.784.78Net Income$23.92M$151.83M$120.31M$225.60M7 Day Performance-12.63%-2.13%-1.92%-1.23%1 Month Performance-3.56%-3.10%11.51%3.36%1 Year Performance-99.19%11.54%30.61%16.60% RedHill Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDHLRedHill Biopharma0.4367 of 5 stars$6.50+0.5%N/A-99.3%$8.33M$3.71M0.00210Gap DownCALCCalciMedica2.9477 of 5 stars$2.76+1.1%$19.33+600.5%-10.1%$37.21MN/A-2.5330Positive NewsTPSTTempest Therapeutics1.8293 of 5 stars$0.84+5.0%$20.00+2,281.0%-80.7%$36.66MN/A0.0020BRNSBarinthus Biotherapeutics1.5332 of 5 stars$0.90-1.4%$5.83+548.1%-67.8%$36.21M$800,000.00-0.61107Gap UpAFMDAffimed4.4532 of 5 stars$2.15flat$13.50+527.9%-68.5%$34.62M$8.95M0.0076Analyst RevisionNews CoverageOKYOOKYO Pharma1.5665 of 5 stars$1.02-3.8%$7.00+586.3%-39.1%$34.52MN/A0.007ANEBAnebulo Pharmaceuticals1.9508 of 5 stars$1.30-7.1%$8.00+515.4%-52.9%$33.71MN/A-4.674News CoverageGap UpVRCAVerrica Pharmaceuticals4.6557 of 5 stars$0.74-3.1%$9.50+1,188.7%-87.7%$33.62M$5.12M-0.4240Analyst ForecastNews CoverageOTLKOutlook Therapeutics1.8277 of 5 stars$1.42-4.1%$42.34+2,881.9%-82.8%$33.60MN/A0.0020SRZNSurrozen1.0796 of 5 stars$10.13+2.8%N/A+32.3%$32.92M$10M0.0042IXHLIncannex HealthcareN/A$1.86+5.1%N/A-54.1%$32.82M$86,000.00-1.343 Related Companies and Tools Related Companies CalciMedica Competitors Tempest Therapeutics Competitors Barinthus Biotherapeutics Competitors Affimed Competitors OKYO Pharma Competitors Anebulo Pharmaceuticals Competitors Verrica Pharmaceuticals Competitors Outlook Therapeutics Competitors Surrozen Competitors Incannex Healthcare Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RDHL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RDHL Stock Alerts